CYTOCHIP Trademark

Trademark Overview


On Wednesday, November 9, 2016, a trademark application was filed for CYTOCHIP with the United States Patent and Trademark Office. The USPTO has given the CYTOCHIP trademark a serial number of 87231661. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, June 4, 2024. This trademark is owned by CytoChip Inc.. The CYTOCHIP trademark is filed in the Medical Instrument Products category with the following description:

Cytometers for medical diagnostic use; Diagnostic apparatus for the detection of cancer; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Hematology analyzers for medical diagnostic uses; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unit; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical device for detecting cancer; Medical device for t...
cytochip

General Information


Serial Number87231661
Word MarkCYTOCHIP
Filing DateWednesday, November 9, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, June 4, 2024
Registration Number5292834
Registration DateTuesday, September 19, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2017

Trademark Statements


Pseudo MarkCYTO CHIP
Goods and ServicesCytometers for medical diagnostic use; Diagnostic apparatus for the detection of cancer; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Hematology analyzers for medical diagnostic uses; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unit; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical device for detecting cancer; Medical device for treating cancer; Medical devices, namely, tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions; Medical diagnostic apparatus for detecting cancer; Medical diagnostic instruments for the analysis of body fluids; Sample preparation device for medical diagnostic uses; Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; Flow cytometers for medical diagnostic uses; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unit; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unit; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unit

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, November 15, 2016
Primary Code010
First Use Anywhere DateWednesday, November 9, 2016
First Use In Commerce DateWednesday, November 9, 2016

Trademark Owner History


Party NameCytoChip Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Party NameCytoChip Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCity of Industry, CA 91748

Party NameCytoChip Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCity of Industry, CA 91748

Trademark Events


Event DateEvent Description
Saturday, November 12, 2016NEW APPLICATION ENTERED
Tuesday, November 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 16, 2016NOTICE OF PSEUDO MARK E-MAILED
Thursday, January 5, 2017ASSIGNED TO EXAMINER
Thursday, January 5, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 22, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, June 22, 2017USE AMENDMENT FILED
Friday, July 21, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, July 22, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, August 11, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, August 12, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 19, 2017REGISTERED-PRINCIPAL REGISTER
Monday, September 19, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 28, 2023TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 4, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 4, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, June 4, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, November 7, 2024TEAS SECTION 7 REQUEST RECEIVED